Bosma PJ - Search Results

1

A genetically retargeted adenoviral vector enhances viral transduction in esophageal carcinoma cell lines and primary cultured esophageal resection specimens.

Buskens CJ, Marsman WA, Wesseling JG, Offerhaus GJ, Yamamoto M, Curiel DT, Bosma PJ, van Lanschot JJ. Buskens CJ, et al. Among authors: bosma pj. Ann Surg. 2003 Dec;238(6):815-24; discussion 825-6. doi: 10.1097/01.sla.0000098622.47909.c0. Ann Surg. 2003. PMID: 14631218 Free PMC article.

2

Gene therapy for esophageal carcinoma: the use of an explant model to test adenoviral vectors ex vivo.

Marsman WA, Buskens CJ, Wesseling JG, Offerhaus GJ, Bergman JJ, Tytgat GN, van Lanschot JJ, Bosma PJ. Marsman WA, et al. Among authors: bosma pj. Cancer Gene Ther. 2004 Apr;11(4):289-96. doi: 10.1038/sj.cgt.7700680. Cancer Gene Ther. 2004. PMID: 14765131

3

Gene therapy for barrett's esophagus: adenoviral gene transfer in different intestinal models.

Marsman WA, Buskens CJ, Wesseling JG, Van Lanschot JJ, Bosma PJ. Marsman WA, et al. Among authors: bosma pj. Cancer Gene Ther. 2005 Sep;12(9):778-86. doi: 10.1038/sj.cgt.7700841. Cancer Gene Ther. 2005. PMID: 15877083

4

The current state of cancer gene therapy and its application in esophageal carcinoma.

Buskens CJ, Marsman WA, Bosma PJ, van Lanschot JJ. Buskens CJ, et al. Among authors: bosma pj. Dig Surg. 2005;22(4):222-33. doi: 10.1159/000088052. Epub 2005 Sep 20. Dig Surg. 2005. PMID: 16174979 Review.

5

Adenoviral serotypes in gene therapy for esophageal carcinoma.

Marsman WA, Wesseling JG, El Bouch A, Bosma PJ, van Lanschot JJ. Marsman WA, et al. Among authors: bosma pj. J Surg Res. 2007 Jun 1;140(1):50-4. doi: 10.1016/j.jss.2006.12.006. Epub 2007 Apr 9. J Surg Res. 2007. PMID: 17418868

6

Prognostic significance of elevated cyclooxygenase 2 expression in patients with adenocarcinoma of the esophagus.

Buskens CJ, Van Rees BP, Sivula A, Reitsma JB, Haglund C, Bosma PJ, Offerhaus GJ, Van Lanschot JJ, Ristimäki A. Buskens CJ, et al. Among authors: bosma pj. Gastroenterology. 2002 Jun;122(7):1800-7. doi: 10.1053/gast.2002.33580. Gastroenterology. 2002. PMID: 12055587

7

Loss of heterozygosity and immunohistochemistry of adenocarcinomas of the esophagus and gastric cardia.

Marsman WA, Birjmohun RS, van Rees BP, Caspers E, Johan G, Offerhaus A, Bosma PJ, Jan J, van Lanschot B. Marsman WA, et al. Among authors: bosma pj. Clin Cancer Res. 2004 Dec 15;10(24):8479-85. doi: 10.1158/1078-0432.CCR-04-0839. Clin Cancer Res. 2004. PMID: 15623628

8

Selection of tumour specific promoters for adenoviral gene therapy of cholangiocarcinoma.

Lie-A-Ling M, Bakker CT, Deurholt T, Hoekstra R, Wesseling JG, Afford SC, Bosma PJ. Lie-A-Ling M, et al. Among authors: bosma pj. J Hepatol. 2006 Jan;44(1):126-33. doi: 10.1016/j.jhep.2005.06.007. Epub 2005 Jul 11. J Hepatol. 2006. PMID: 16168519

9

Ephrin A2 receptor targeting does not increase adenoviral pancreatic cancer transduction in vivo.

van Geer MA, Bakker CT, Koizumi N, Mizuguchi H, Wesseling JG, Oude Elferink RP, Bosma PJ. van Geer MA, et al. Among authors: bosma pj. World J Gastroenterol. 2009 Jun 14;15(22):2754-62. doi: 10.3748/wjg.15.2754. World J Gastroenterol. 2009. PMID: 19522026 Free PMC article.

10

A fiber modified adenovirus vector that targets to the EphrinA2 receptor reveals enhanced gene transfer to ex vivo pancreatic cancer.

Van Geer MA, Brevoord D, Kuhlmann KF, Bakker CT, Mizuguchi H, Wesseling JG, Ten Kate FJ, Gouma DJ, Oude Elferink RP, Bosma PJ. Van Geer MA, et al. Among authors: bosma pj. Int J Oncol. 2010 Jan;36(1):233-44. Int J Oncol. 2010. PMID: 19956852

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

96 results

Search Page

Filters